Publisher
source

Universidad de Zaragoza

Just Landed

Postdoctoral Researcher in Aptamer Technology and SELEX at the University of Zaragoza (I3A) University of Zaragoza in Spain

Degree Level

Postdoc

Field of study

Molecular Biology

Funding

Available

Deadline

Oct 9, 2026

Country flag

Country

Spain

University

Universidad de Zaragoza

Social connections

How do I apply for this?

Sign in for free to reveal details, requirements, and source links.

More information can be found here

Keywords

Molecular Biology
Biomedical Engineering
Biotechnology
Biology
Coronary Artery Disease
Organ-on-chip Technology
Biomedicine
bio engineering

Suggested positions

About this position

Postdoctoral opportunity at the Aragón Institute of Engineering Research (I3A), University of Zaragoza, Spain, for a researcher with strong expertise in aptamer identification by SELEX. The project is centered on the discovery of first-in-class therapeutic molecules for cardiac disease, with aptamers used both as active pathway modulators and as targeted delivery vehicles.

The work combines functional screening in advanced human in vitro models, including heart-on-chip platforms, within a multidisciplinary environment spanning molecular biology, stem cell-based tissue engineering, advanced in vitro models, and translational research. The position sits in the laboratories of Dr. Laura Ordovás and Dr. Jesús Ciriza at I3A, a leading institute with state-of-the-art infrastructure at the interface of engineering and biomedicine.

This postdoctoral role is designed for candidates who intend to apply to competitive fellowship schemes, specifically Juan de la Cierva 2026 and the EMBO postdoctoral program. The institute offers full institutional support for preparing applications, access to organ-on-chip and advanced human in vitro platforms, and opportunities to develop scientific independence, contribute to grant proposals, and supervise students and junior researchers.

Eligibility highlights include a PhD in Molecular Biology, Biochemistry, Biotechnology, Biomedicine, or a related area, a strong publication record, excellent written and spoken English, and direct practical experience with SELEX methodologies such as cell-SELEX and/or in vivo SELEX. For EMBO, the posting also notes requirements related to the timing of the PhD, first-author publication record, and international mobility. The application deadline listed is 2026-10-09.

To apply, candidates should email a CV with publication metrics, a motivation letter, and contact details for two references to the listed contacts at the University of Zaragoza.

Funding details

Available

What's required

PhD in Molecular Biology, Biochemistry, Biotechnology, Biomedicine, or a related field. Candidates should have a strong publication record, preferably including high-impact first-author papers, and a strong scientific trajectory suitable for competitive postdoctoral applications. Demonstrated hands-on experience in SELEX methodologies, including cell-SELEX and/or in vivo SELEX, for aptamer selection and characterization is required. A high level of written and spoken English is required, and the post is aimed at researchers with 4–10 years of research experience.

How to apply

Send a CV including publication metrics, a motivation letter, and contact information for two references by email to [email protected] and [email protected]. Use the email contact provided in the posting to apply.

Ask ApplyKite AI

Start chatting
Can you summarize this position?
What qualifications are required for this position?
How should I prepare my application?